drug discovery - REACH RIGHT FASTER

Proteros is a Munich-based provider of  structure-based early stage drug discovery  services with a cutting-edge discovery engine tailored to unlock even the most technically challenging drug targets.

Proteros supports its clients to reach the right results and accelerate their overall research timelines, helping them to open the door to lead optimization and clinical programs.

Proteros' work is built on scientific excellence, having been founded on Nobel prize-winning science.

We stand for reliable results, excellence in project execution and utmost customer orientation and agility.

We call this REACH RIGHT FASTER.

Proteros building 1 Proteros building 1

HIGH HANGING FRUITS 

Todays drug discovery is more and more about technically challenging, unprecedented drug targets. These are often multi-subunit protein complexes, membrane or membrane associated proteins such as GPCRs or ion channels or simply protein constructs with a distinct physiologically relevant function. Often these targets are hard to access and to make available in the RIGHT composition.

We call these targets “high hanging fruits” and help our customers to establish the right enabling technologies for all their discovery approaches. This opens the door to subsequently successful lead discovery and clinical programs.

Based on our scientific excellence we are the experts in high hanging fruits.

palm-only2

Excellence is our main asset

Lamp

Reliable Results

Our scientific expertise warrants the design of scientifically relevant experiments that ultimately reach the right outcomes. Only the right solutions and insights help our customers avoid downstream risk and accelerate overall research timelines.

Arrow

Excellent Execution

Excellence in project execution is fundamental - we deliver what we promise, we reach the milestones, meet timelines and agreed budgets. When unexpected outcomes are encountered, we communicate in a proactive and goal oriented, forward looking manner.

People Interaction

Agile Interaction

We are committed to our clients and their challenges. We do not just want to perform a service but deliver the right solution and solve challenges in close cooperation. We are agile in thinking and the way we act.

What can Proteros do for you?

Our Drug Discovery Services
DiscoverySolutions_icon_LINE

DRUG DISCOVERY

We act as our clients’ discovery engine to apply our enabling Discovery Solutions technology platform and expertise  in an early drug discovery "target-to-qualified hits" manner . Alternatively, you can select service components from our service portfolio as your project demands.

Learn more

Crystallography_icon_LINES

X-RAY

Elucidation of even the most complex structures through the preparation of the RIGHT protein and application of high-resolution protein crystallography and/or cryo-EM.

Learn more

CryoEM_icon_LINES

CRYO-EM

The science and technology platform to deliver the RIGHT challenging proteins and complexes.

Learn more

ProteinScience_icon_LINES

PROTEIN SCIENCE

At the heart of everything we do is the RIGHT protein for the right experiment. It’s knowing the protein has the right functionality, right construct, right homogeneity, right post-translational modifications, right complex composition, right stability, right species, right activity and right purity as well.

Learn more

Biologics_icon_LINES

BIOLOGICS

At Proteros we take care about the rightful expression, analytics-driven high-quality purification, biochemical, biophysical and structural characterization as well as early developability assessment (non GxP) for your complex biologics / antigen in a “one-stop-shop” approach.

Learn more

AssaysBiophysicsScreening_Line_icon

ASSAYS, BIOPHYSICS & SCREENING

At Proteros you can pick and choose from a wealth of affinity, binding and kinetics assay principles covering enzymatic, biochemical and biophysical assays. Our portfolio covers pre-established assays and customized assay development for profiling and screening applications.

Learn more

FIND A gallery product

Proteins, Structures and Assays

VIEW ALL GALLERY PRODUCTS

News & events

Sept 06, 2023

News

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with full chemistry support of Enamine

READ MORE

Jan 09, 2023

News

Proteros receives minority investment from private equity firm Inflexion

READ MORE

Oct 25, 2022

News

Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

READ MORE

May 16, 2022

News

Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca

READ MORE